Patient-specific models of apoptosis execution, based on the concentrations of these molecules determined in samples of stage II and III colorectal tumors, showed a trend towards impaired apoptosis execution with advanced disease stage and correlated with disease relapse after adjuvant chemotherapy.
1
—
—